In line with SFDA’s concerns about evaluation of critical drugs, and in view of the cooperation between SFDA Drug Sector and European Medicines Evaluation Agency (EMA), a Two- day workshop was organized to train SFDA Drug Evaluation personnel on evaluation of drugs files
The workshop was opened by H.E. Dr. Mohammed Ahmed Al Kanhal, CEO –SFDA and participated by Dr. Fal Ahmen and Dr. Quid Hue from EMA and addressed three key dimensions covering the quality of drug products, EU & GCC Drug Regulations and other technical and professional issues.
It worth mentioning that the workshop was attended by several professionals and interested groups from GCC Countries.